carbamates has been researched along with quinazolines in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (41.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, Y; Ishikawa, M | 2 |
| Egughi, Y; Ishikawa, M; Kaneshiro, S | 1 |
| Houslay, MD; Price, B; Pyne, NJ | 1 |
| Clifford, JM; Cookson, JH; Wickham, PE | 1 |
| Hishida, S; Mizoi, Y; Tanabe, T; Ueda, M | 1 |
| Chrusciel, TL; Isbell, H | 1 |
| Carlier, J; D'Orio, V; el Allaf, D | 1 |
| Been, M; Hillis, WS | 1 |
| Baird, JR; Blackburn, KJ; Cambridge, D; Constantine, JW; Ghaly, MS; Hayden, ML; McIlhenny, HM; Moore, PF; Olukotun, AY; Pullman, LG; Salsburg, DS; Saxton, CA; Shevde, S; Taylor, CR | 1 |
| Gallant, JE | 1 |
| Gergely, A; Gyimesi-Forrás, K; Kökösi, J; Lindner, W; Szász, G | 1 |
| Ahn, SK; Choi, H; Choi, NS; Hwang, IC; Im, DS; Kim, SJ; Kim, SW; Kim, YH; Lee, HW; Lee, J; Lee, KJ; Lee, SS; Moon, SK | 1 |
| Bai, S; Bhadury, PS; Fan, H; Hu, D; Lu, P; Song, B; Yang, S; Zhang, X; Zhang, Y | 1 |
| Arlot, Y; Depreux, P; Farce, A; Garofalo, A; Goossens, L; Lemoine, A | 1 |
| Golabi, N; Huang, Y; Jean-Claude, BJ; Qiu, Q; Rachid, Z | 1 |
| Belavic, JM | 1 |
| Ait-Tihyaty, M; Jean-Claude, BJ; Larroque-Lombard, AL; Rachid, Z | 1 |
| Miyamoto, T; Yoshimoto, G | 1 |
| Birkeland, AC; Bradford, CR; Brenner, JC; Carey, TE; Foltin, SK; Komarck, CM; Ludwig, ML; Mann, JE; McHugh, JB; Michmerhuizen, NL; Prince, ME; Sandelski, MM; Scott, MV; Spector, ME; Tillman, BN; Yanik, M | 1 |
| Beijnen, JH; Rood, JJM; Rosing, H; Schellens, JHM; Sparidans, RW | 1 |
| Chen, Y; Gavish, M; Huang, W; Liang, J; Marek, I; Ouyang, F; Singh, S; Veenman, L; Zeng, J | 1 |
| Azrad, M; Gavish, M; Veenman, L; Weizman, A; Zeineh, N | 1 |
| Amara, R; Gavish, M; Monga, S; Nagler, R; Weizman, A | 1 |
5 review(s) available for carbamates and quinazolines
| Article | Year |
|---|---|
Dependence liability of "non-narcotic" drugs.
Topics: Alcohols; Amphetamine; Barbiturates; Benzazepines; Carbamates; Chloral Hydrate; Dronabinol; Ephedrine; Esters; Ethers, Cyclic; Glycols; Hallucinogens; Halogens; Herbicides; Humans; Indoles; Phenethylamines; Piperidines; Plant Extracts; Quinazolines; Substance-Related Disorders | 1970 |
The new inotropic phosphodiesterase inhibitors.
Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines | 1984 |
Phosphodiesterase inhibitors: haemodynamic effects related to the treatment of cardiac failure.
Topics: Aminophylline; Animals; Carbamates; Heart Failure; Heart Rate; Hemodynamics; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Quinazolines; Stimulation, Chemical | 1982 |
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
Topics: Animals; Asthma; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ethanolamines; Heart Failure; Hemodynamics; Humans; Hypertension; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
[Treatment strategy for myeloproliferative neoplasms].
Topics: Adrenal Cortex Hormones; Aspirin; Calreticulin; Carbamates; Clinical Trials as Topic; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Immunosuppressive Agents; Janus Kinase 2; Molecular Targeted Therapy; Mutation; Nitriles; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Pyrazoles; Pyrimidines; Quinazolines; Receptors, Thrombopoietin; Thalidomide; Thrombocythemia, Essential | 2014 |
2 trial(s) available for carbamates and quinazolines
| Article | Year |
|---|---|
Absorption and clearance of secobarbital, heptabarbital, methaqualone, and ethinamate.
Topics: Adult; Alkynes; Barbiturates; Carbamates; Chromatography, Gas; Clinical Trials as Topic; Cycloheptanes; Cyclohexanes; Half-Life; Humans; Hypnotics and Sedatives; Intestinal Absorption; Male; Methaqualone; Phenobarbital; Quinazolines; Regression Analysis; Secobarbital; Time Factors | 1974 |
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
Topics: Animals; Asthma; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ethanolamines; Heart Failure; Hemodynamics; Humans; Hypertension; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
18 other study(ies) available for carbamates and quinazolines
| Article | Year |
|---|---|
[Synthetic studies of antiatherogenic agents. (VII) Syntheses of methylcarbamate of substituted quinazolinones (author's transl)].
Topics: Arteriosclerosis; Carbamates; Chemical Phenomena; Chemistry; Ethyl Ethers; Quinazolines | 1977 |
[Synthetic studies on antiatherogenic agents (III) syntheses of carbamate derivative of quinazolinones (author's transl)].
Topics: Arteriosclerosis; Carbamates; Quinazolines | 1975 |
Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Amrinone; Animals; Carbamates; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dogs; Kinetics; Milrinone; Myocardium; Peptide Hydrolases; Pyridazines; Pyridones; Quinazolines; Trypsin | 1987 |
[Synthetic studies on antiatherogenic agents (I). Syntheses of carbamate derivatives of diazines (author's transl)].
Topics: Arteriosclerosis; Carbamates; Phthalazines; Quinazolines | 1974 |
Experimental studies on the detection of hypnotics using thin layer chromatography.
Topics: Animals; Barbiturates; Carbamates; Chromatography, Thin Layer; Glutethimide; Hypnotics and Sedatives; Phenobarbital; Quinazolines; Rabbits; Stomach; Urea | 1972 |
New antiretroviral agents.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Carbamates; Deoxycytidine; Dioxolanes; Drugs, Investigational; Emtricitabine; Furans; Guanosine; HIV Fusion Inhibitors; Humans; Imidazoles; Oligopeptides; Organophosphates; Organophosphonates; Organophosphorus Compounds; Prodrugs; Protease Inhibitors; Pyridines; Pyrones; Quinazolines; Reverse Transcriptase Inhibitors; Sulfonamides; Sulfur Compounds; Tenofovir | 2001 |
Liquid chromatographic enantiomer separations of novel quinazolone derivatives on quinine carbamate based chiral stationary phases using hydro-organic mobile phases.
Topics: Buffers; Carbamates; Quinazolines; Stereoisomerism; Temperature; Thermodynamics | 2004 |
Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533).
Topics: Administration, Oral; Animals; Carbamates; Catalytic Domain; Computer Simulation; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Microsomes, Liver; Phosphodiesterase 5 Inhibitors; Quinazolines; Rabbits; Rats | 2010 |
Enantioseparation and plant virucidal bioactivity of new quinazoline derivatives with alpha-aminophosphonate moiety.
Topics: 2-Propanol; Amylose; Antiviral Agents; Carbamates; Chromatography, High Pressure Liquid; Hexanes; Organophosphonates; Quinazolines; Reproducibility of Results; Stereoisomerism; Temperature; Thermodynamics; Tobacco Mosaic Virus | 2010 |
Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer.
Topics: Amides; Antineoplastic Agents; Carbamates; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Male; Prostatic Neoplasms; Protein Kinase Inhibitors; Quinazolines; Urea; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
In vitro and in vivo biodistribution of ZRS1, a stabilized type I N-acetoxymethyl carbamate-containing combi-molecule.
Topics: Animals; Carbamates; Cell Aggregation; Cell Line, Tumor; ErbB Receptors; Female; Humans; Male; Mice; Mice, Inbred BALB C; Prodrugs; Quinazolines; Tissue Distribution; Triazenes | 2011 |
Annual drug update: 2011 in review.
Topics: Abatacept; Aminoglycosides; Carbamates; Drug Approval; Fentanyl; Fidaxomicin; Humans; Immunoconjugates; Indans; Linagliptin; Phenylenediamines; Proline; Purines; Quinazolines; Quinolones; United States; United States Food and Drug Administration | 2012 |
ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carbamates; Carboxylesterase; Cell Line, Tumor; Deoxycytidine; ErbB Receptors; Fluorouracil; Humans; Hydrolysis; Mice; Mice, Inbred BALB C; Neoplasms; Quinazolines; Thymidine Phosphorylase | 2013 |
Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
Topics: Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Carbamates; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; ErbB Receptors; Gene Expression Profiling; Humans; Hydroxybutyrates; Immunohistochemistry; Laryngeal Neoplasms; Mouth Neoplasms; Mutation; Purines; Quinazolines; Receptor, ErbB-2; Retrospective Studies; Triazines | 2016 |
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O-desmethyl metabolites of erlotinib and gefitinib in human plasma.
Topics: Administration, Oral; Adult; Afatinib; Aged; Aged, 80 and over; Calibration; Carbamates; Chromatography, Liquid; Drug Monitoring; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Male; Middle Aged; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Quinazolines; Reproducibility of Results; Sulfonamides; Tandem Mass Spectrometry | 2016 |
2-Cl-MGV-1 Ameliorates Apoptosis in the Thalamus and Hippocampus and Cognitive Deficits After Cortical Infarct in Rats.
Topics: Animals; Apoptosis; Carbamates; Cerebral Infarction; Cognitive Dysfunction; Hippocampus; Male; Maze Learning; Membrane Potential, Mitochondrial; Memory; Mitochondria; Neuroglia; Neurons; Neuroprotective Agents; Quinazolines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, GABA; Thalamus | 2017 |
The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS.
Topics: Animals; Blotting, Western; Carbamates; Cell Line; Inflammation; Isoquinolines; Lipopolysaccharides; Mice; Microglia; Quinazolines; Receptors, GABA | 2019 |
Inhibitory Effects of the Two Novel TSPO Ligands 2-Cl-MGV-1 and MGV-1 on LPS-induced Microglial Activation.
Topics: Animals; Carbamates; Cell Line; Cytokines; Inflammation; Ligands; Lipopolysaccharides; Microglia; Quinazolines; Reactive Oxygen Species; Receptors, GABA; Transcription Factor RelA | 2019 |